TrialPanorama/TrialPanorama-database huggingface dataset:
Study 35889747 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 35889747 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 33856385 — Predictive Biomarker (PRD): ERAS mRNA
Genes: ERAS; HRAS2; HRASP
Study 33856385 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34778910 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 35950566 — Predictive Biomarker (PRD): RET mRNA
Genes: RET; CDHF12; CDHR16; PTC; RET51
Study 36459413 — Safety Biomarker (SAF): Hyaluronic acid
Study 32897905 — Surrogate Endpoint (SUR): Blood pressure
Study 32712560 — Predictive Biomarker (PRD): CBS mRNA
Genes: CBS
Study 32861652 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 32301744 — Surrogate Endpoint (SUR): Blood pressure
Study 34593045 — Predictive Biomarker (PRD): SHANK3 mRNA
Genes: SHANK3; KIAA1650; PROSAP2; PSAP2
Study 33563017 — Surrogate Endpoint (SUR): Blood pressure
Study 34083234 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study 34083234 — Monitoring Biomarker (MOI): Cell-free DNA
Study 34083234 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study 33022096 — Predictive Biomarker (PRD): TOX mRNA
Genes: TOX; KIAA0808
Study 33022096 — Predictive Biomarker (PRD): REL mRNA
Genes: REL
Study 33470732 — Surrogate Endpoint (SUR): Blood pressure
Study 36353346 — Predictive Biomarker (PRD): HAL mRNA
Genes: HAL; HIS
Study 35510164 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study 36149841 — Surrogate Endpoint (SUR): Blood pressure
Study 33894370 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 35030333 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor receptor
Study 34624497 — Predictive Biomarker (PRD): DNA excision repair protein ERCC-1
Genes: ERCC1
Study 34624497 — Predictive Biomarker (PRD): Thymidylate synthase 
Genes: TYMS; TS; OK/SW-cl.29
Study 36115360 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study 32729662 — Predictive Biomarker (PRD): FOXO1 mRNA
Genes: FOXO1; FKHR; FOXO1A
Study 32729662 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study 32729662 — Safety Biomarker (SAF): Fatty acid binding protein 1
Genes: FABP1; FABPL
Study 32729662 — Predictive Biomarker (PRD): GSTA2 mRNA
Genes: GSTA2; GST2
Study 32729662 — Predictive Biomarker (PRD): ACSL1 mRNA
Genes: ACSL1; FACL1; FACL2; LACS; LACS1; LACS2
Study 32729662 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study 33407777 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study 33407777 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33407777 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 33048456 — Safety Biomarker (SAF): SLCO1B1
Genes: OATP-C; LST-1; OATP1B1
Study 33048456 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study 33448580 — Surrogate Endpoint (SUR): Blood pressure
Study 32408396 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study 32408396 — Predictive Biomarker (PRD): MYC mRNA
Genes: MYC; BHLHE39
Study 32408396 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study 32408396 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 33332454 — Surrogate Endpoint (SUR): Forced vital capacity
Study 36222880 — Surrogate Endpoint (SUR): Blood pressure
Study 33991134 — Surrogate Endpoint (SUR): Forced vital capacity
Study 33516531 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study 35220641 — Predictive Biomarker (PRD): EIF2S1 mRNA
Genes: EIF2S1; EIF2A
Study 32489274 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study 33974324 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study 35224797 — Predictive Biomarker (PRD): LBP mRNA
Genes: LBP
Study 35167133 — Predictive Biomarker (PRD): FGFR1
Genes: H2; H3; H4; H5; CEK; FLG; BFGFR; N-SAM; CD331
Study 37179020 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 35314457 — Predictive Biomarker (PRD): TNFRSF1A mRNA
Genes: TNFRSF1A; TNFAR; TNFR1
Study 35314457 — Predictive Biomarker (PRD): TNFRSF1B mRNA
Genes: TNFRSF1B; TNFBR; TNFR2
Study 35314457 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 36104613 — Predictive Biomarker (PRD): NLRP3 mRNA
Genes: NLRP3; C1orf7; CIAS1; NALP3; PYPAF1
Study 36104613 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34324783 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 33645135 — Surrogate Endpoint (SUR): Serum creatinine
Study 32989062 — Surrogate Endpoint (SUR): Blood pressure
Study 32583541 — Predictive Biomarker (PRD): LOXL1 mRNA
Genes: LOXL1; LOXL
Study 34814908 — Predictive Biomarker (PRD): SDS mRNA
Genes: SDS; SDH
Study 34814908 — Predictive Biomarker (PRD): TSPAN31 mRNA
Genes: TSPAN31; SAS
Study 35882814 — Predictive Biomarker (PRD): SRL mRNA
Genes: SRL
Study 32107360 — Predictive Biomarker (PRD): TRPV1 mRNA
Genes: TRPV1; VR1
Study 32107360 — Predictive Biomarker (PRD): TRPA1 mRNA
Genes: TRPA1; ANKTM1
Study 32281732 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 35696071 — Predictive Biomarker (PRD): EFS mRNA
Genes: EFS; CASS3
Study 32892317 — Predictive Biomarker (PRD): TF mRNA
Genes: TF; PRO1400
Study 32892317 — Predictive Biomarker (PRD): KLHL17 mRNA
Genes: KLHL17; AF
Study 32439205 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 33472779 — Surrogate Endpoint (SUR): Blood pressure
Study 32232721 — Predictive Biomarker (PRD): HGS mRNA
Genes: HGS; HRS
Study 35845459 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PSD mRNA
Genes: PSD; EFA6; EFA6A; KIAA2011; PSD1; TYL
Study 32497146 — Predictive Biomarker (PRD): CAPS mRNA
Genes: CAPS
Study 33676014 — Predictive Biomarker (PRD): COMP mRNA
Genes: COMP
Study 33676014 — Predictive Biomarker (PRD): C2 mRNA
Genes: C2
Study 33812261 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32970198 — Surrogate Endpoint (SUR): Bone mineral density
Study 36283750 — Safety Biomarker (SAF): Hyaluronic acid
Study 36283750 — Surrogate Endpoint (SUR): Blood pressure
Study 34386961 — Predictive Biomarker (PRD): HDAC8 mRNA
Genes: HDAC8; HDACL1; CDA07
Study 33973407 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32868028 — Surrogate Endpoint (SUR): Bone mineral density
Study 34705573 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 32585854 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 36071165 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 36071165 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study 32845589 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HP mRNA
Genes: HP
Study 35265033 — Predictive Biomarker (PRD): TPO mRNA
Genes: TPO
Study 35265033 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study 34343214 — Predictive Biomarker (PRD): MACC1 mRNA
Genes: MACC1
Study 32234755 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 32234755 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 32234755 — Predictive Biomarker (PRD): Ki-67
Genes: MKI67; MIB-1; PPP1R105
Study 34322079 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study 32751219 — Surrogate Endpoint (SUR): Blood pressure
Study 35172560 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 35194193 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 33515770 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study 33515770 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study 34793361 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 32920297 — Predictive Biomarker (PRD): TFPI mRNA
Genes: TFPI; LACI; TFPI1
Study 35818238 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 35818238 — Monitoring Biomarker (MOI): Procalcitonin
Study 34498056 — Predictive Biomarker (PRD): JAK1
Genes: JAK1A; JTK3
Study 34836025 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 34836025 — Safety Biomarker (SAF): Transforming growth factor beta 1
Genes: TGFB1; TGFB
Study 34836025 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 32708511 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study 35793833 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 35793833 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 36223695 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 34170392 — Surrogate Endpoint (SUR): Blood pressure
Study 34609773 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 32843370 — Surrogate Endpoint (SUR): Total kidney volume
Study 34971025 — Predictive Biomarker (PRD): AMIGO1 mRNA
Genes: AMIGO1; ALI2; AMIGO; KIAA1163
Study 33782504 — Predictive Biomarker (PRD): FGF21 mRNA
Genes: FGF21; UNQ3115/PRO10196
Study 33782504 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study 33782504 — Safety Biomarker (SAF): BDNF
Study 32916135 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study 34708441 — Predictive Biomarker (PRD): EMD mRNA
Genes: EMD; EDMD; STA
Study 36122268 — Predictive Biomarker (PRD): CFP mRNA
Genes: CFP; PFC
Study 32744040 — Monitoring Biomarker (MOI): Complement C7
Genes: C7
Study 34348347 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32088296 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 19
Genes: FGF19; UNQ334/PRO533
Study 32088296 — Predictive Biomarker (PRD): NR1H4 mRNA
Genes: NR1H4; BAR; FXR; HRR1; RIP14
Study 34149030 — Predictive Biomarker (PRD): ABR mRNA
Genes: ABR
Study 35425986 — Predictive Biomarker (PRD): FANCE mRNA
Genes: FANCE; FACE
Study 34551495 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 32189663 — Surrogate Endpoint (SUR): Blood pressure
Study 32887990 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study 32276019 — Predictive Biomarker (PRD): DAP mRNA
Genes: DAP; DAP1
Study 32409439 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 33773059 — Pharmacodynamic Biomarker (PDY): Platelet-derived growth factor B
Genes: PDGFB; PDGF2; SIS
Study 36269726 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 36269726 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 36269726 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HP mRNA
Genes: HP
Study 33020647 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study 33020647 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 33758158 — Surrogate Endpoint (SUR): Blood pressure
Study 35352593 — Predictive Biomarker (PRD): TTR mRNA
Genes: TTR; PALB
Study 32022106 — Surrogate Endpoint (SUR): Blood pressure
Study 35289182 — Predictive Biomarker (PRD): TTR mRNA
Genes: TTR; PALB
Study 35289182 — Surrogate Endpoint (SUR): Blood pressure
Study 33305662 — Predictive Biomarker (PRD): PBX1 mRNA
Genes: PBX1; PRL
Study 35334797 — Surrogate Endpoint (SUR): Plasma ammonia
Study 34704430 — Surrogate Endpoint (SUR): Sperm parameters
Study 34935139 — Predictive Biomarker (PRD): GEM mRNA
Genes: GEM; KIR
Study 34321048 — Predictive Biomarker (PRD): COMP mRNA
Genes: COMP
Study 34321048 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33439574 — Safety Biomarker (SAF): Neutrophil to lymphocyte
Study 32546963 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study 32546963 — Predictive Biomarker (PRD): CYP2C9 mRNA
Genes: CYP2C9; CYP2C10
Study 32451125 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 35413886 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 35413886 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 34441930 — Predictive Biomarker (PRD): GLS mRNA
Genes: GLS; GLS1; KIAA0838
Study 35527126 — Predictive Biomarker (PRD): ANGPTL8 mRNA
Genes: ANGPTL8; C19orf80; RIFL; UNQ599/PRO1185
Study 35841944 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 32820698 — Surrogate Endpoint (SUR): Bone mineral density
Study 35472115 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Adrenomedullin
Genes: ADM; AM
Study 33935080 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study 33511392 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 35788416 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 35133468 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 35133468 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 35133468 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 35133468 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 33676969 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 35786525 — Predictive Biomarker (PRD): MBL2 mRNA
Genes: MBL2; COLEC1; MBL
Study 33559134 — Predictive Biomarker (PRD): SNAP25 mRNA
Genes: SNAP25; SNAP
Study 33812203 — Predictive Biomarker (PRD): TES mRNA
Genes: TES
Study 616787628 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 616787628 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 34032504 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study 33245949 — Predictive Biomarker (PRD): CCND1 mRNA
Genes: CCND1; BCL1; PRAD1
Study 33245949 — Predictive Biomarker (PRD): FGFR1 mRNA
Genes: FGFR1; BFGFR; CEK; FGFBR; FLG; FLT2; HBGFR
Study 33245949 — Predictive Biomarker (PRD): IGF1R mRNA
Genes: IGF1R
Study 33245949 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study 35186237 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 35186237 — Predictive Biomarker (PRD): SELENBP1 mRNA
Genes: SELENBP1; SBP
Study 35186237 — Surrogate Endpoint (SUR): Blood pressure
Study 35446936 — Predictive Biomarker (PRD): EFS mRNA
Genes: EFS; CASS3
Study 33462752 — Predictive Biomarker (PRD): ROS1
Genes: MCF3; ROS; c-ros-1
Study 33462752 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study 32460816 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 32460816 — Predictive Biomarker (PRD): Ki-67
Genes: MKI67; MIB-1; PPP1R105
Study 32450154 — Surrogate Endpoint (SUR): Serum creatinine
Study 32256955 — Predictive Biomarker (PRD): PLA2G1B mRNA
Genes: PLA2G1B; PLA2; PLA2A; PPLA2
Study 32209396 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study 32209396 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 32209396 — Predictive Biomarker (PRD): ASRGL1 mRNA
Genes: ASRGL1; ALP; CRASH
Study 32209396 — Predictive Biomarker (PRD): TLR2 mRNA
Genes: TLR2; TIL4
Study 32209396 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 33793979 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 33793979 — Predictive Biomarker (PRD): Hormone receptor
Study 32869451 — Predictive Biomarker (PRD): PYY mRNA
Genes: PYY
Study 33596357 — Predictive Biomarker (PRD): Hormone receptor
Study 33596357 — Surrogate Endpoint (SUR): Bone mineral density
Study 34053111 — Predictive Biomarker (PRD): ID1 mRNA
Genes: ID1; BHLHB24; ID
Study 34053111 — Predictive Biomarker (PRD): NID1 mRNA
Genes: NID1; NID
Study 34053111 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study 34053111 — Predictive Biomarker (PRD): RB1
Genes: RB; PPP1R130
Study 34053111 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HP mRNA
Genes: HP
Study 34144995 — Surrogate Endpoint (SUR): Blood pressure
Study 33002071 — Surrogate Endpoint (SUR): Blood pressure
Study 35247908 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 35247908 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Tumor mutational burden
Study 32216011 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32216011 — Surrogate Endpoint (SUR): Serum uric acid
Study 35222898 — Safety Biomarker (SAF): Aminopeptidase N
Genes: ANPEP; APN; CD13; PEPN
Study 35222898 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Endothelin-1
Genes: EDN1
Study 35222898 — Pharmacodynamic Biomarker (PDY): Matrix metalloproteinase 9
Genes: MMP9; CLG4B
Study 35818134 — Predictive Biomarker (PRD): TSLP mRNA
Genes: TSLP
Study 34800399 — Safety Biomarker (SAF): Lysosomal alpha-glucosidase
Genes: GAA
Study 34800399 — Surrogate Endpoint (SUR): Forced vital capacity
Study 34800399 — Pharmacodynamic Biomarker (PDY): Antidrug antibody
Study 34087752 — Predictive Biomarker (PRD): GSR mRNA
Genes: GSR; GLUR; GRD1
Study 33741218 — Safety Biomarker (SAF): Hyaluronic acid
Study 32048900 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PSD mRNA
Genes: PSD; EFA6; EFA6A; KIAA2011; PSD1; TYL
Study 32048900 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 34716791 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34716791 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 32660609 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 32660609 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 32660609 — Predictive Biomarker (PRD): Hormone receptor
Study 36477733 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study 36477733 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study 32095884 — Surrogate Endpoint (SUR): Blood pressure
Study 32696396 — Predictive Biomarker (PRD): DHODH mRNA
Genes: DHODH
Study 32696396 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33741010 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 35699175 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study 32495059 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 32495059 — Surrogate Endpoint (SUR): Blood pressure
Study 32495059 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 34809581 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 34466041 — Predictive Biomarker (PRD): EBF1 mRNA
Genes: EBF1; COE1; EBF
Study 34021585 — Predictive Biomarker (PRD): MMD mRNA
Genes: MMD; PAQR11
Study 34844978 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 34844978 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 34844978 — Predictive Biomarker (PRD): Hormone receptor
Study 34844978 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study 35554859 — Surrogate Endpoint (SUR): Blood pressure
Study 36397173 — Surrogate Endpoint (SUR): Blood pressure
Study 35704124 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 34040607 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 32927677 — Surrogate Endpoint (SUR): Blood pressure
Study 32202124 — Predictive Biomarker (PRD): PPT1 mRNA
Genes: PPT1; CLN1; PPT
Study 34529156 — Safety Biomarker (SAF): Hyaluronic acid
Study 32393980 — Predictive Biomarker (PRD): LBP mRNA
Genes: LBP
Study 32393980 — Predictive Biomarker (PRD): CD14 mRNA
Genes: CD14
Study 34228592 — Surrogate Endpoint (SUR): Blood pressure
Study 32783769 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 34024173 — Predictive Biomarker (PRD): REM1 mRNA
Genes: REM1; GES; REM
Study 34879822 — Surrogate Endpoint (SUR): Blood pressure
Study 33010188 — Safety Biomarker (SAF): Interleukin 12
Study 34284381 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 32453116 — Predictive Biomarker (PRD): GAST mRNA
Genes: GAST; GAS
Study 35002817 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32573426 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 36349701 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study 36349701 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 33768310 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study 36455187 — Predictive Biomarker (PRD): AADAC mRNA
Genes: AADAC; DAC
Study 32168870 — Predictive Biomarker (PRD): ADORA2A mRNA
Genes: ADORA2A; ADORA2
Study 33332778 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 33759644 — Surrogate Endpoint (SUR): Blood pressure
Study 32646941 — Predictive Biomarker (PRD): ANGPTL3 mRNA
Genes: ANGPTL3; ANGPT5; UNQ153/PRO179
Study 32646941 — Predictive Biomarker (PRD): LDLR mRNA
Genes: LDLR
Study 36128889 — Surrogate Endpoint (SUR): Bone mineral density
Study 36128889 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study 33266022 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Interleukin 17
Genes: IL17A; CTLA8; IL17
Study 33266022 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study 33266022 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 36228567 — Surrogate Endpoint (SUR): Blood pressure
Study 34732114 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 34814584 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4